Physiologic Monitoring
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
15
NCT01456065
Safety of Active Immunotherapy in Subjects With Ovarian Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2010
Completion: Apr 30, 2013
Loading map...